Congress debates decriminalising magic mushrooms in DC as representative claims it would make area ‘drug capital’

Representatives on the House Appropriations Committee have debated the status of magic mushrooms and other psychedelic drugs in Washington, DC, after activists called for them to be decriminalised in a petition.

Last week, activists submitted a petition with 36,000 signatures to the Board of Elections, that they say is enough to get the decriminalisation of natural hallucinogens in the district on the ballot in November, according to the Associated Press.

If the motion is successful, then it would follow similar laws passed in Denver, Colorado, and California cities Oakland and Santa Cruz, where natural hallucinogens, have been decriminalised in recent years.

Melissa Lavasani, who proposed the initiative and claimed using the mushrooms helped treat her postpartum depression, said the activists are focused on promoting the therapeutic and medical benefits of the drugs.

“DC could really lead the way on this,” Ms Lavasani told the AP. “You shouldn’t bear the repercussions of the drug war while you are healing yourself.”

However, Maryland representative Andy Harris, proposed forbidding a voter initiative on the policy on Wednesday, and argued that “we certainly — I would hope — don’t want to be known as the drug capital of the world.”

His amendment, which also called for the use of psychedelics to be still be banned without a doctors recommendation, was backed by other Republicans, who suggested that decriminalising the drugs would be dangerous, according to the New York Post.

“We all can agree that policies that increase the availability of psychedelic drugs in the nation’s capital — that’s dangerous,” said Republican representative Tom Graves.

“As the nation’s capital, the District of Columbia, it should be a place where Americans come to see their government at work, for history and to go to a Braves-Nats game. It shouldn’t be a destination for illegal drugs,” he added.

However, Democrats on the committee criticised Mr Harris’ proposed amendment and said that the vote is a choice for the public, not politicians.

“If the district’s residents want to make mushrooms a lower priority and focus limited law enforcement resources on other issues, that is their prerogative,” Illinois congressman Mike Quigley argued.

The health benefits of using natural hallucinogens has long been debated, but a study at New York University’s Grossman School of Medicine earlier this year found that a single dose of psilocybin, a compound found in psychedelic mushrooms, could have long-term positive effects.

The study into psilocybin, found that in conjunction with psychotherapy, cancer patients experienced improvements in emotional and existential distress five years after they had been administered just one dose.

“Participants overwhelmingly (71 to 100 per cent) attributed positive life changes to the psilocybin-assisted therapy experience and rated it among the most personally meaningful and spiritually significant experiences of their lives,” the researchers said of the study from 2016 to 2020.

Mr Harris later withdraw his amendment, but released a statement where he said he would revisit it if the motion is on the ballot in November.

“This is a new issue to the committee,” he said. “Between now and the meeting of the conference committee this fall, the issue of whether this will be on the ballot will be resolved.

“Fortunately, in that time, members will also have time to learn more about this complicated medical issue.”